Anorexia/ Cachexia Clinical Trials & Research at Providence Medical Group

Providence Medical Group is currently enrolling patients for the following Anorexia/ Cachexia clinical trials:


Study to Assess the Effect of PF-06946860 on Appetite Following Subcutaneous Administration to Patients with Anorexia and Advanced Cancer(Pfizer C3651010​)

Treatment agent: PF-06946860
PI: Sara Keck, MD
Study Coordinator: Melissa Phillips // Melissa.Phillips2@stjoe.org// (707) 521-3833 ext. 1313
Resources and Links: https://clinicaltrials.gov/ct2/show/NCT04803305?term=PF-06946860&draw=2&rank=2
Sponsor: Pfizer